u/Acceptable_Way_28

We got to July 20th 2026 for public comment on how the DEA fucked us with the strict API methods used for pharmactical companies!

Everyone comment! It closes public comment on July 20th 2026! Only way to get our voices heard!

https://www.federalregister.gov/documents/2026/05/20/2026-10128/revision-of-applications-for-manufacturing-and-procurement-quotas

You’d think with how rich and powerful these companies are, they’d probably have someone monitoring or checking in on what the public is saying. Or maybe they’re at a point where they don’t care bc of how powerful and untouchable they are.

What do you think their reactions are to us screaming and agonizing over how our lives have been destroyed impacted?

If our drugs don’t start getting better soon, or maybe it’s too late for all of us. They fucked up but also have shown us how little human lives mean to those in power.
They’ve taught us to keep theorizing with that in mind. They’ve taught us to trust nobody.

These companies and those in charge are real monsters. Disgusting.

Let’s get them to care

**Here’s a concise media tip template you could send to reporters, health desks, or investigative outlets. You can personalize it with your own experiences and any documentation you have.**

Hello,

I’m reaching out because many ADHD patients across the U.S. are reporting serious problems related to stimulant medications, including inconsistent availability, abrupt changes between manufacturers, and concerns about effectiveness compared to previous years.

Online communities, pharmacies, and patient groups contain thousands of reports describing:
\- difficulty obtaining prescribed medications
\- sudden changes in symptom control after manufacturer switches
\- impacts on employment, education, relationships, and daily functioning
\- stress caused by ongoing shortages and refill instability

Many patients feel their concerns are being dismissed individually, even though similar experiences are being reported nationwide.

I believe this could warrant deeper investigation into:
\- ongoing stimulant shortages
\- manufacturing and supply chain issues
\- DEA production quotas
\- generic manufacturer variability
\- barriers patients face when trying to report concerns

I and others may be willing to share timelines, pharmacy records, medication photos, or documented experiences if your newsroom is interested.

Thank you for your time.

Spread the word

Let’s get them to care

**Here’s a concise media tip template you could send to reporters, health desks, or investigative outlets. You can personalize it with your own experiences and any documentation you have.**

Hello,

I’m reaching out because many ADHD patients across the U.S. are reporting serious problems related to stimulant medications, including inconsistent availability, abrupt changes between manufacturers, and concerns about effectiveness compared to previous years.

Online communities, pharmacies, and patient groups contain thousands of reports describing:
\- difficulty obtaining prescribed medications
\- sudden changes in symptom control after manufacturer switches
\- impacts on employment, education, relationships, and daily functioning
\- stress caused by ongoing shortages and refill instability

Many patients feel their concerns are being dismissed individually, even though similar experiences are being reported nationwide.

I believe this could warrant deeper investigation into:
\- ongoing stimulant shortages
\- manufacturing and supply chain issues
\- DEA production quotas
\- generic manufacturer variability
\- barriers patients face when trying to report concerns

I and others may be willing to share timelines, pharmacy records, medication photos, or documented experiences if your newsroom is interested.

Thank you for your time.

Here’s a pre-written email to send to your state reps. I’m sick of feeling helpless

We NEED to make it known that this medication is not only not working, but making us ill. I LITERALLY LOST MY PERIOD FROM IT!!!!

Here’s a basic email, feel free to add any extreme side affects that have been ailing you and really push the hazardous nature of these bunk meds.

Dear \[Senator/Representative Name\],

I am a constituent writing to express concern about the ongoing Adderall (amphetamine mixed salts) shortage and emerging quality issues with generic versions of this medication.

While I understand that federal agencies such as the DEA and FDA play different roles in regulating supply and drug standards, the current situation is failing patients. Despite recent adjustments to production quotas, access to consistent and effective medication remains unreliable.

In addition, I have personally experienced significant differences in the effectiveness and side effects of generic Adderall from the same manufacturer (Teva), along with noticeable changes in the physical appearance of the medication between refills. These inconsistencies raise concerns about manufacturing quality, bioequivalence standards, and oversight.

I respectfully urge your office to:

\- Investigate whether current DEA production quota policies are adequately aligned with legitimate medical demand

\- Encourage increased transparency and accountability from manufacturers regarding formulation consistency

\- Support FDA oversight to ensure generic medications meet not only bioequivalence standards, but also consistent real-world effectiveness

For many patients, this is not a minor inconvenience — it directly affects our ability to function, work, and maintain daily responsibilities.

Thank you for your time and attention to this issue.

Sincerely,

\[Your Name\]

\[Your ZIP Code\]

Here’s a concise media tip template you could send to reporters, health desks, or investigative outlets. You can personalize it with your own experiences and any documentation you have.

Hello,

I’m reaching out because many ADHD patients across the U.S. are reporting serious problems related to stimulant medications, including inconsistent availability, abrupt changes between manufacturers, and concerns about effectiveness compared to previous years.

Online communities, pharmacies, and patient groups contain thousands of reports describing:
- difficulty obtaining prescribed medications
- sudden changes in symptom control after manufacturer switches
- impacts on employment, education, relationships, and daily functioning
- stress caused by ongoing shortages and refill instability

Many patients feel their concerns are being dismissed individually, even though similar experiences are being reported nationwide.

I believe this could warrant deeper investigation into:
- ongoing stimulant shortages
- manufacturing and supply chain issues
- DEA production quotas
- generic manufacturer variability
- barriers patients face when trying to report concerns

I and others may be willing to share timelines, pharmacy records, medication photos, or documented experiences if your newsroom is interested.

Thank you for your time.

I JUST remembered back in spring of 2020:
I was sitting around going stir crazy from COVID isolation, so I downloaded TikTok.
A woman on there was using self-censored code words to refer to Adderall and Xanax and complaining about how those words were censored from social media, which propagates negative views on them and the people who need them to function.
Do you think they did that so no one could talk about these issues openly? I mean they certainly put their all into hiding this stuff from the public.

We NEED to make it known that this medication is not only not working, but making us ill. I LITERALLY LOST MY PERIOD FROM IT!!!!

Here’s a basic email, feel free to add any extreme side affects that have been ailing you and really push the hazardous nature of these bunk meds.

Dear [Senator/Representative Name],

I am a constituent writing to express concern about the ongoing Adderall (amphetamine mixed salts) shortage and emerging quality issues with generic versions of this medication.

While I understand that federal agencies such as the DEA and FDA play different roles in regulating supply and drug standards, the current situation is failing patients. Despite recent adjustments to production quotas, access to consistent and effective medication remains unreliable.

In addition, I have personally experienced significant differences in the effectiveness and side effects of generic Adderall from the same manufacturer (Teva), along with noticeable changes in the physical appearance of the medication between refills. These inconsistencies raise concerns about manufacturing quality, bioequivalence standards, and oversight.

I respectfully urge your office to:

- Investigate whether current DEA production quota policies are adequately aligned with legitimate medical demand

- Encourage increased transparency and accountability from manufacturers regarding formulation consistency

- Support FDA oversight to ensure generic medications meet not only bioequivalence standards, but also consistent real-world effectiveness

For many patients, this is not a minor inconvenience — it directly affects our ability to function, work, and maintain daily responsibilities.

Thank you for your time and attention to this issue.

Sincerely,

[Your Name]

[Your ZIP Code]

Years ago I was sending out these emails to try and keep a specific plant-based substance legal in my state. I got the copy-paste body for the emails from an activist who was leading the movement to try and protect plant based medicines. Do we have anything like that? Because I’m sure all of us want to do whatever is in our power to get our meds back, yet if anyone’s adhd is close to half as bad as mine I know we’re all struggling to even keep ourselves alive. If there’s anyone who’s already written to their state reps and can share a template we can all use we might be able to make enough noise!